Stockreport

Banking on the long-term potential of oncology drugs: Daiichi Sankyo CFO [CNBC]

DAIICHI SANKYO S/ADR  (DSNKY) 
PDF Koji Ogawa, CFO of Daiichi Sankyo, discusses the company's shifting focus towards its oncology portfolio on the back of earnings. [Read more]